Breaking news and analysis from time.com. Politics, world news, photos, video, tech reviews, health, science, and ...
Shares of Moderna (NASDAQ:MRNA) are up 14% to $68 and change in afternoon trading Friday, extending a remarkable run for the ...
Pfizer said it will seek regulatory approval for a Lyme disease vaccine candidate despite failing a late-stage trial. Pfizer said not enough people contracted Lyme disease to be confident in the ...
Add Yahoo as a preferred source to see more of our stories on Google. Donald Trump has repeatedly accused Pfizer of helping Joe Biden win the 2020 election - Francis Chung/Politico/Bloomberg Donald ...
It’s just an extra vaccination that’s added onto your vaccination record, so I don’t see why it’s so complicated,” one mom said of the COVID-19 shot.
After a period of unsteady sales for its key COVID-19 products, Pfizer now sees COVID-related revenue volatility as “largely in the past.” In an investor presentation (PDF) Tuesday, the company made ...
Pfizer will work with Robert F. Kennedy Jr. if he's confirmed as the new secretary of the HHS, Pfizer CEO Albert Bourla said on Tuesday. (Photo by FABRICE COFFRINI/AFP via Getty Images) As one of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results